Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-24-084950

Options or other derivatives

  • President and CEO acquired 22,325 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
White Marvin L President and CEO 2024-07-17 Grant or award · Restricted Stock Unit +22,325 22,325 D
Loading xslF345X05/ownership.xml…